Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-08 4:15 pm Purchase | 2025-03-31 | 13G | Scilex Holding Company SCLX | ORAMED PHARMACEUTICALS INC. ORMP | 732,717 9.900% | 289,860 (+65.45%) | Filing History |
| 2025-01-23 9:21 pm Sale | 2025-01-21 | 13D | Scilex Holding Company SCLX | SCLX Stock Acquisition JV LLC | 2,302,484 21.100% | -115,125 (-4.76%) | Filing History |
| 2025-01-17 4:15 pm Purchase | 2025-01-13 | 13G | Scilex Holding Company SCLX | ORAMED PHARMACEUTICALS INC. ORMP | 442,857 6.200% | 442,857 (New Position) | Filing History |
| 2025-01-06 7:11 pm Sale | 2025-01-02 | 13D | Scilex Holding Company SCLX | SCLX Stock Acquisition JV LLC | 2,417,609 22.800% | -142,857 (-5.58%) | Filing History |
| 2024-09-09 4:11 pm Purchase | 2024-08-30 | 13D | DENALI CAP ACQUISITION CORP CL DNQAF | Scilex Holding Co SCLX | 500,000 39.900% | 500,000 (New Position) | Filing History |
| 2024-04-25 5:25 pm Unchanged | 2024-04-25 | 13D | Scilex Holding Company SCLX | SCLX Stock Acquisition JV LLC | 2,560,466 33.300% | 0 (Unchanged) | Filing History |
| 2024-03-05 4:22 pm Unchanged | 2024-03-05 | 13D | Scilex Holding Company SCLX | SCLX Stock Acquisition JV LLC | 2,560,466 36.400% | 0 (Unchanged) | Filing History |
| 2024-01-31 5:24 pm Unchanged | 2023-11-30 | 13D | Scilex Holding Company SCLX | SCLX Stock Acquisition JV LLC | 2,560,466 38.200% | 0 (Unchanged) | Filing History |
| 2023-09-29 4:15 pm Purchase | 2023-09-21 | 13D | Scilex Holding Company SCLX | SCLX Stock Acquisition JV LLC | 2,560,466 39.300% | 2,560,466 (New Position) | Filing History |
| 2023-09-26 4:49 pm Sale | 2023-09-21 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 54,777 1.300% | -2,674,751 (-97.99%) | Filing History |
| 2023-08-14 8:59 pm Unchanged | 2023-08-07 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 2,729,529 43.300% | 0 (Unchanged) | Filing History |
| 2023-03-03 09:10 am Unchanged | 2023-02-21 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 2,729,529 44.200% | 0 (Unchanged) | Filing History |
| 2023-02-13 1:52 pm Unchanged | 2022-12-31 | 13G | Scilex Holding Company SCLX | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-01-23 4:33 pm Sale | 2023-01-19 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 2,729,529 45.500% | -2,067,262 (-43.10%) | Filing History |
| 2022-12-09 4:21 pm Sale | 2022-11-30 | 13G | Vickers Vantage Corp. I VCKA | KARPUS MANAGEMENT, INC. | 0 0.000% | -1,737,145 (Position Closed) | Filing History |
| 2022-11-17 5:09 pm Purchase | 2022-11-10 | 13D | Scilex Holding Company SCLX | Sorrento Therapeutics Inc. SRNEQ | 4,796,791 96.300% | 4,796,791 (New Position) | Filing History |
| 2022-11-14 09:14 am Sale | 2022-11-09 | 13G | Vickers Vantage Corp. I VCKA | Feis Lawrence | 0 0.000% | -753,037 (Position Closed) | Filing History |
| 2022-07-27 3:33 pm Purchase | 2022-07-26 | 13G | Vickers Vantage Corp. I VCKA | Feis Lawrence | 753,037 5.720% | 753,037 (New Position) | Filing History |
| 2022-02-14 3:28 pm Purchase | 2021-12-31 | 13G | Vickers Vantage Corp. I VCKA | CVI Investments, Inc. | 749,600 4.300% | 749,600 (New Position) | Filing History |
| 2022-02-11 2:19 pm Purchase | 2021-12-31 | 13G | Vickers Vantage Corp. I VCKA | Shaolin Capital Management LLC | 1,325,779 7.700% | 1,325,779 (New Position) | Filing History |